Normal view

Received — 10 September 2026 ⏭

Nature - Issue - nature.com science feeds
Proximity-guided graph learning reveals tumour-associated proximity antigens Cody Scandore · Clare F. Malone · Christopher K. May · Anna K. de Regt · Jeff Guernsey · Hayley Ma · Noah Dephoure · Ben Setter · Rebecca A. Howell · Kendall R. Johnson · Carol L. Farr · Sophia Romero · Lydia Vignale · Tali Vittum · Emma Dawson · Tsadik Habtetsion · Francesca Nardi · Brian Woodruff · Martin Mathay · Julia Swanson · Mikaela Rusnak · Quynh Ton · Payam E. Farahani · Robert W. Gene · Jason Misurelli · Zach Caldwell · Hengyu Xu · Michael Hornsby · Marc A. Gavin · Heath E. Klock · Ertan Eryilmaz · Pamela M. Holland · Scott A. Lesley · Rob C. Oslund · Olugbeminiyi O. Fadeyi
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11003-7A proximity-mapping atlas defines tumour-associated proximity antigens, revealing disease-associated membrane spatial communities, and identifies EGFR–CDCP1 as a co-target pair that enhances tumour killing by multispecific therapeutics.
9 September 2026 at 08:00

Proximity-guided graph learning reveals tumour-associated proximity antigens

Nature - Issue - nature.com science feeds

By: Cody Scandore · Clare F. Malone · Christopher K. May · Anna K. de Regt · Jeff Guernsey · Hayley Ma · Noah Dephoure · Ben Setter · Rebecca A. Howell · Kendall R. Johnson · Carol L. Farr · Sophia Romero · Lydia Vignale · Tali Vittum · Emma Dawson · Tsadik Habtetsion · Francesca Nardi · Brian Woodruff · Martin Mathay · Julia Swanson · Mikaela Rusnak · Quynh Ton · Payam E. Farahani · Robert W. Gene · Jason Misurelli · Zach Caldwell · Hengyu Xu · Michael Hornsby · Marc A. Gavin · Heath E. Klock · Ertan Eryilmaz · Pamela M. Holland · Scott A. Lesley · Rob C. Oslund · Olugbeminiyi O. Fadeyi

9 September 2026 at 08:00

Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11003-7

A proximity-mapping atlas defines tumour-associated proximity antigens, revealing disease-associated membrane spatial communities, and identifies EGFR–CDCP1 as a co-target pair that enhances tumour killing by multispecific therapeutics.